JCO Precision Oncology : Impact Factor & More
eISSN: 2473-4284pISSN: 2473-4284
Share this on:
Key Metrics
CiteScore 
6.6
Eigenfactor
0.005 - 0.01
Impact Factor
< 5
SJR
Q2Oncology
SNIP
0.98
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on JCO Precision Oncology
JCO Precision Oncology Journal Specifications
Indexed in the following public directories
Web of Science 
SJR
| Overview | |
| Publisher | LIPPINCOTT WILLIAMS & WILKINS |
| Language | English |
| Frequency | Continuous publication |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2017 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in JCO Precision Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in JCO Precision Oncology
Prognostic Value of MammaPrint in Diverse Populations: Evaluating Racial Disparities in Breast Cancer Outcomes.
- 1 Apr 2026
- JCO precision oncology
Living Guidelines for Tumor-Agnostic Therapies: A Pathway to Next-Generation Cancer Treatment.
- 1 Apr 2026
- JCO precision oncology
Increasing Use of Germline Genetic Testing in Pancreatic Ductal Adenocarcinoma and Relationship to Clinical Outcome: A Single-Institution Study.
- 1 Apr 2026
- JCO precision oncology
Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Gastroesophageal Adenocarcinoma.
- 1 Apr 2026
- JCO precision oncology
Does Longitudinal Targeted Panel Sequencing Provide Clinically Relevant Information in Translocation-Associated Sarcomas?
- 1 Apr 2026
- JCO precision oncology
Biomarker Testing Rates and Patterns in Patients With Metastatic Non-Small Cell Lung Cancer: A Prospective, Observational Study in Community Practices.
- 1 Apr 2026
- JCO precision oncology
Prognostic Value of MammaPrint in Diverse Populations: Evaluating Racial Disparities in Breast Cancer Outcomes.
- 1 Apr 2026
- JCO precision oncology
Living Guidelines for Tumor-Agnostic Therapies: A Pathway to Next-Generation Cancer Treatment.
- 1 Apr 2026
- JCO precision oncology
Increasing Use of Germline Genetic Testing in Pancreatic Ductal Adenocarcinoma and Relationship to Clinical Outcome: A Single-Institution Study.
- 1 Apr 2026
- JCO precision oncology
Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Gastroesophageal Adenocarcinoma.
- 1 Apr 2026
- JCO precision oncology
Does Longitudinal Targeted Panel Sequencing Provide Clinically Relevant Information in Translocation-Associated Sarcomas?
- 1 Apr 2026
- JCO precision oncology
Biomarker Testing Rates and Patterns in Patients With Metastatic Non-Small Cell Lung Cancer: A Prospective, Observational Study in Community Practices.
- 1 Apr 2026
- JCO precision oncology
FAQs on JCO Precision Oncology
How long has JCO Precision Oncology been actively publishing? 
What is the publishing frequency of JCO Precision Oncology?
How many articles did JCO Precision Oncology publish last year?
What is the eISSN & pISSN for JCO Precision Oncology?
What is Citescore for JCO Precision Oncology?
What is SNIP score for JCO Precision Oncology?
What is the SJR for JCO Precision Oncology?
Who is the publisher of JCO Precision Oncology?
